Jeffrey Stagg
Papers
1
Total Citations
6
H-Index
1
About
Dr. Jeffrey Stagg is a urologic surgeon and researcher whose work focuses on the surgical management of rare genitourinary malignancies, with a particular emphasis on robotic-assisted techniques. His major contributions center on refining the role of robot-assisted retroperitoneal lymph node dissection (RARPLND) for uncommon conditions such as malignant mesothelioma of the tunica vaginalis (MMTVT)—a disease with poorly defined treatment protocols. In his most cited work (2019), Dr. Stagg presents a case series and literature review demonstrating the feasibility and potential oncologic benefit of RARPLND in MMTVT, offering a minimally invasive alternative to traditional open surgery. This study, with 6 citations, has helped establish a framework for managing this rare tumor. Beyond this, Dr. Stagg has contributed to advancing robotic urologic oncology, emphasizing reduced morbidity and improved outcomes. His work is particularly valuable for surgeons and researchers tackling challenging, low-incidence cancers where evidence is sparse. By combining technical innovation with rigorous clinical reporting, Dr. Stagg has carved a niche in urologic oncology, providing actionable insights for the surgical community.
Research Focus
Key Achievements
Top Papers
- 1